Sunbelt Securities’s Humacyte HUMA Stock Holding History

Sunbelt Securities’s Portfolio HUMA Stock Details HUMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$106	Buy	174 +171	+5,700%	+$178	﹤0.01%	2643
2025 Q4	$3	Buy	+3	New	+$4	﹤0.01%	2781

Other funds holding HUMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sunbelt Securities's HUMA Position: Q1 2026 in Review

Sunbelt Securities increased its Humacyte (HUMA) stake by 5,700% in Q1 2026, buying an estimated $178 and bringing the position to 174 shares worth $106. The position accounts for ﹤0.01% of the portfolio, ranked #2643.

Sunbelt Securities first reported a position in HUMA in Q4 2025 and has held it in 2 quarters since. 159 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

Sunbelt Securities held 174 shares of Humacyte worth $106 as of Q1 2026.
Sunbelt Securities bought 171 Humacyte shares in Q1 2026, an estimated $178.
Humacyte made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2643 holding.
Sunbelt Securities first reported a position in Humacyte in Q4 2025 and has held it in 2 quarters since.
159 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.